Quarterly report [Sections 13 or 15(d)]

Financial Instruments (Tables)

v3.25.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2025
Text Block [Abstract]  
Summary of Fair Value Hierarchy of Company's Financial Assets and Financial Liabilities

The following table summarizes the fair value hierarchy for the Company’s financial assets and financial liabilities that are re-measured at their fair values periodically:

 

 

 

As of March 31, 2025

 

As of December 31, 2024

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

Level 1

 

Level 2

 

Level 3

 

Total

Financial assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long term investments

 

$

6

 

$

 

$

836

 

$

842

 

$

10

 

$

 

$

853

 

$

863

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

$

 

$

 

$

3,109

 

$

3,109

 

$

 

$

 

$

3,127

 

$

3,127

Summary of Changes in Level One and Level Three Financial Assets

The following table summarizes the changes in Level 1 and Level 3 financial assets:

 

 

Financial Assets

 

 

 

4Front Venture Corp.

 

 

The Pharm Stand, LLC

 

 

Island Thyme, LLC

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2024

 

$

10

 

$

125

 

$

728

Additions

 

 

 

 

 

 

Revaluations

 

 

(4)

 

 

 

 

Loss on equity method investments

 

 

 

 

 

 

(17)

Balance as of March 31, 2025

 

$

6

 

$

125

 

$

711

Summary of changes in level three financial assets and liabilities

The following table summarizes the changes in the Company's Level 3 financial liabilities:

 

 

 

Financial Liabilities

 

 

 

Contingent Consideration Payable

 

 

 

 

Balance as of December 31, 2024

 

$

3,127

Consideration paid

 

 

Revaluations

 

 

(18)

Balance as of March 31, 2025

 

$

3,109

Summary of Long-term Debt Instruments at Carrying Value and Fair Value

The following table summarizes the Company’s long-term debt instruments (Note 5) at their carrying value and fair value:

 

 

As of March 31, 2025

 

As of December 31, 2024

 

 

Carrying Value

 

Fair Value

 

Carrying Value

 

Fair Value

June Unsecured Debentures

 

$

22,495

 

$

21,152

 

$

21,750

 

$

20,142

June Secured Debentures

 

 

148,720

 

 

139,947

 

 

144,913

 

 

134,096

Secured Notes

 

 

11,901

 

 

12,233

 

 

14,968

 

 

15,223

Other

 

 

 

 

 

 

696

 

 

687

Total

 

$

183,116

 

$

173,332

 

$

182,327

 

$

170,148